Bo‐Rong Pan
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Bo-Rong Pan's research interests encompass several distinct areas, as indicated by a diverse publication record. Recent work includes investigating genetic variants associated with reduced risk for drug-induced acute liver failure in a specific population and exploring the safety, tolerability, pharmacokinetics, and preliminary efficacy of a bi-ligand-drug conjugate in patients with advanced solid tumors. Pan has also contributed to studies on biodiversity conservation in arid lands, the phylogeny and taxonomic relationships of plant species using morphological and molecular markers, and the genetic diversity of tree species. Scholarship metrics include an h-index of 19, with 106 total publications and 1,325 total citations. Pan has collaborated with Minjun Chen and Tsung-Jen Liao, both from the National Center for Toxicological Research, on shared publications.
Metrics
- h-index: 19
- Publications: 106
- Citations: 1,341
Selected Publications
-
Genetic Variants of <i>GBP4</i>: Reduced Risks for Drug‐Induced Acute Liver Failure in Non‐Finnish European Population (2025)
Collaboration Network
Top Collaborators
- Genetic Variants of <i>GBP4</i>: Reduced Risks for Drug‐Induced Acute Liver Failure in Non‐Finnish European Population
- Genetic Variants of <i>GBP4</i>: Reduced Risks for Drug‐Induced Acute Liver Failure in Non‐Finnish European Population
- Genetic Variants of <i>GBP4</i>: Reduced Risks for Drug‐Induced Acute Liver Failure in Non‐Finnish European Population
- Genetic Variants of <i>GBP4</i>: Reduced Risks for Drug‐Induced Acute Liver Failure in Non‐Finnish European Population
- Genetic Variants of <i>GBP4</i>: Reduced Risks for Drug‐Induced Acute Liver Failure in Non‐Finnish European Population
- Genetic Variants of <i>GBP4</i>: Reduced Risks for Drug‐Induced Acute Liver Failure in Non‐Finnish European Population
- Genetic Variants of <i>GBP4</i>: Reduced Risks for Drug‐Induced Acute Liver Failure in Non‐Finnish European Population
- Genetic Variants of <i>GBP4</i>: Reduced Risks for Drug‐Induced Acute Liver Failure in Non‐Finnish European Population
- Genetic Variants of <i>GBP4</i>: Reduced Risks for Drug‐Induced Acute Liver Failure in Non‐Finnish European Population
- Genetic Variants of <i>GBP4</i>: Reduced Risks for Drug‐Induced Acute Liver Failure in Non‐Finnish European Population
- Genetic Variants of <i>GBP4</i>: Reduced Risks for Drug‐Induced Acute Liver Failure in Non‐Finnish European Population
Similar Researchers
Based on overlapping research topics